Sponsors: []Modifications:     63A-1-115.(1)  For purposes of this section, "state entity" includes:(a)  an employer who participates in the Public Employees' Benefit and InsuranceProgram created in Title 49, Chapter 20, Public Employees' Benefit and Insurance ProgramAct


;(b)  state institutions of higher education;(c)  state institutions of public education;(d)  except to the extent federal Medicaid funding is involved as provided in Subsection(4)(b)(iii), the state:(i)  Developmental Center;(ii)  psychiatric hospital; and(iii)  child welfare system;(e)  the Department of Corrections;(f)  the state's Comprehensive Health Insurance Pool created in Title 31A, Chapter 29,Comprehensive Health Insurance Pool Act; and(g)  political subdivisions of the state which pay for or arrange for the payment ofprescription drugs.(2) (a)  There is created within the department, the Aggregate Prescription DrugPurchasing Committee to assist the department with developing and implementing anaggregate prescription drug purchasing program in accordance with this section.(b)  The department shall provide staff and administrative support to the committee.(3)  The committee shall consist of:(a)  a representative selected by the Public Employees' Benefit and Insurance Programcreated in Title 49, Chapter 20, Public Employees' Benefit and Insurance Program Act;(b)  a representative from the Insurance Commission selected by the Commissioner ofInsurance;(c)  a representative from the Department of Health selected by the executive director ofthe Department of Health;(d)  a representative from the Comprehensive Health Insurance Pool, created in Title31A, Chapter 29, Comprehensive Health Insurance Pool Act, selected by the board of directorsof the pool;(e)  a representative from the Department of Human Services selected by the executivedirector of the Department of Human Services;(f)  a representative of higher education appointed by the State Board of Regents;(g)  a representative of public education appointed by the State School Board;(h)  a representative appointed by the Utah School Board's Association;(i)  a representative appointed by the State Office of Education;(j)  two representatives appointed by the Utah Association of School Business Officialsas follows:(i)  one representative from a local rural school district; and(ii)  one representative from an urban local school district;(k)  a representative from the Department of Corrections appointed by the executivedirector of the department; and(l)  a representative of a political subdivision in the state appointed by the UtahAssociation of Counties.(4) (a)  The department:(i)  shall establish an aggregate prescription drug purchasing program, in accordancewith this section, through which terms are negotiated related to the purchase of prescriptiondrugs by a state entity that provides coverage for prescription drugs or arranges for the paymentof the costs of prescription drugs; and(ii)  shall not implement or maintain the aggregate prescription drug purchasingprogram established under Subsection (4)(a)(i), until:(A)  the audit report by the Legislative Auditor General's Office required by Subsection(6); and(B)  after July 1, 2007.(b) (i)  A state entity as defined in Subsection (1) shall participate in the aggregate drugpurchasing program established by this section.(ii)  Any state, district, county, city, municipality, public agency, or governmental entityother than a state entity defined in Subsection (1) may elect to participate in the aggregateprescription drug purchasing program established by this section.(iii)  The state Medicaid program may participate in the aggregate prescription drugpurchasing program to the extent:(A)  permitted by federal law; and(B)  participation in the plan would reduce the Medicaid program's costs forprescription drugs.(5)  The department, in consultation with the committee, may:(a)  investigate and implement options and strategies to achieve the greatest savings onprescriptions drugs with prescription drug manufacturers and wholesalers;(b)  appoint and contract with a pharmaceutical benefits manager or any other entity todo any of the following:(i)  negotiate price discounts, rebates, or other options that achieve the greatest savingson prescription drugs with prescription drug manufacturers and wholesalers;(ii)  purchase prescription drugs for participating state, district, county, or municipalgovernmental employees; or(iii)  act as a consultant to the department; or(c)  explore additional strategies for managing the increasing costs of prescriptiondrugs, including:(i)  coordinating programs offered by pharmaceutical manufacturers that provideprescription drugs for free or at reduced prices;(ii)  study the feasibility and appropriateness of including in the aggregate purchasingprograms entities in the private sector, including employers, providers, and individualconsumers;(iii)  implementing other strategies, as permitted under state and federal law, aimed atmanaging escalating prescription drug prices; and(iv)  enter into agreements with other states to jointly purchase prescription drugs in theaggregate to reduce the prescription drug costs for the state.(6) (a)  On or before October 1, 2006, the department shall submit a report to theLegislative Auditor General's Office on activities that have been or will be undertaken pursuantto this section.  The report shall include all of the following:(i)  the number and description of contracts that are contemplated with manufacturersand suppliers of drugs, including any rebates, discounts, or refunds to be obtained under thecontracts;(ii)  the number and a description of state entities participating in the coordinatedpurchasing program;(iii)  other options and strategies that have been or will be implemented under theprogram; and(iv)  estimated costs and savings attributable to activities that have been or will beundertaken pursuant to this section.(b)  The Legislative Auditor General will conduct an audit of the program proposedunder this section and shall submit the results of the audit to the Legislature before January 1,2007.(7)  Information that includes prescription drug prices and discounts or other proprietaryinformation, trade secrets, or commercial information provided to the committee or to thedepartment under the provisions of this section may be classified as protected records inaccordance with Section 

63-2-304

 of the Government Records Access and Management Act.Full text:



Utah State Legislature












Legislators

By Session (1896-Current)
Alphabetical (Historical)
Find by Address/Map
More


Bills

Bills/Bill Requests
Passed Bills
2017 Bills

Keyword Search
Reading Calendars
Tracking Service
More


Committees

All Committees
Appropriations
Commissions

Independent Legislative Ethics Commission
Interim
Standing
Subcommittees
Task Forces
Bills In Committees


Utah Code / Constitution


Title/Chapter/Section
Keyword Search 

Utah Constitution
Laws of Utah 1851-ongoing
Utah Territorial Laws 
More


Senate

Main Page 
About The Senate 
Leadership 
Roster 
Seating Chart 
District Maps 
Extraordinary Sessions 
Reading Calendars 
Past Floor Debates 
Senate Journals 


House

Main Page
About the House 
Leadership 
Roster 
Seating Chart 
District Maps 
Reading Calendars 
Past Floor Debates 
Journals 
Conflict of Interest Forms 


Legislative Guide 

Legislative Guide
Civic Programs
GRAMA (Records Requests)


Publications

Search Publications
Appropriations
Audits
Bagels & Briefings
Briefing Papers
Digest of Legislation
Legislative Drafting Manual

Journals

Interim Highlights

Legislative Rules
GRAMA (Records Requests)
Public Email
State Organization Charts
YouTube Channel
Requests for Proposals and Legal Notices
More


Legislative Histories

Legislative History Resources
How to Research
Bill Drafting/Research Files (1990-Ongoing)

Working Bills (1896-1989)
Interim Committee Histories (1990-Ongoing) 
Journals
Past House Floor Debates
Past Senate Floor Debates
More


Staff Offices

All Legislative Offices
Auditor General
Fiscal Analyst
Printing
Research and General Counsel
Staff Awards
Job Opportunities
More


Links of Interest

Utah Administrative Rules
Courts
Utah State Capitol
State of Utah
Federal Legislation
More






 

Download Zipped Introduced WordPerfect HB0079.ZIP
[Status][Bill Documents][Fiscal Note][Bills Directory]


H.B. 79





            
1

    
 PRESCRIPTION DRUG PURCHASING POOLS



            
2

    
2006 GENERAL SESSION

            
3

    
STATE OF UTAH

            
4

    


 Chief Sponsor:  Bradley G. Last



            
5

    



Senate Sponsor:  






____________





            
6

    

            
7

    
 LONG TITLE
            
8

    
 General Description:
            
9

    
    This bill requires the Department of Administrative Services to develop a plan for bulk
            
10

    
purchasing of prescription drugs and other cost-saving measures for the purchase of
            
11

    
prescription drugs by state entities.
            
12

    
 Highlighted Provisions:
            
13

    
    This bill:
            
14

    
    .    defines the state entities subject to the bulk purchasing plan;
            
15

    
    .    creates an advisory committee within the Department of Administrative Services
            
16

    
which consists of representatives of state entities subject to the bulk purchasing
            
17

    
requirements;
            
18

    
    .    instructs the Department of Administrative Services, with the advice of the
            
19

    
committee, to develop a plan for cost savings for state funded prescription drugs;
            
20

    
    .    prohibits the implementation of any prescription drug plan until:
            
21

    
        .    the department reports to the Legislative Auditor General;
            
22

    
        .    the Legislative Auditor General conducts an audit of the plan; and
            
23

    
        .    after July, 1, 2007; and    
            
24

    
    .    provides protection of trade secrets and proprietary information regarding drug
            
25

    
prices, discounts, and rebates.
            
26

    
 Monies Appropriated in this Bill:
            
27

    
    None


            
28


     
 Other Special Clauses:
            
29

    
    None
            
30

    
 Utah Code Sections Affected:
            
31

    
ENACTS:
            
32

    
     63A-1-115, Utah Code Annotated 1953
            
33

    

            
34

    
Be it enacted by the Legislature of the state of Utah:
            
35

    
    Section 1.  
Section  
63A-1-115

 is enacted to read:
            
36

    
     63A-1-115.  Aggregate purchasing of prescription drugs.
            
37

    
    (1)  For purposes of this section, "state entity" includes:
            
38

    
    (a)  an employer who participates in the Public Employees' Benefit and Insurance
            
39

    
Program created in Title 49, Chapter 20, Public Employees' Benefit and Insurance Program
            
40

    
Act


;
            
41

    
    (b)  state institutions of higher education;
            
42

    
    (c)  state institutions of public education;
            
43

    
    (d)  except to the extent federal Medicaid funding is involved as provided in Subsection
            
44

    
(4)(b)(iii), the state:
            
45

    
    (i)  Developmental Center;
            
46

    
    (ii)  psychiatric hospital; and
            
47

    
    (iii)  child welfare system;
            
48

    
    (e)  the Department of Corrections;
            
49

    
    (f)  the state's Comprehensive Health Insurance Pool created in Title 31A, Chapter 29,
            
50

    
Comprehensive Health Insurance Pool Act; and
            
51

    
    (g)  political subdivisions of the state which pay for or arrange for the payment of
            
52

    
prescription drugs.
            
53

    
    (2) (a)  There is created within the department, the Aggregate Prescription Drug
            
54

    
Purchasing Committee to assist the department with developing and implementing an
            
55

    
aggregate prescription drug purchasing program in accordance with this section.
            
56

    
    (b)  The department shall provide staff and administrative support to the committee.
            
57

    
    (3)  The committee shall consist of:
            
58

    
    (a)  a representative selected by the Public Employees' Benefit and Insurance Program


            
59


    
created in Title 49, Chapter 20, Public Employees' Benefit and Insurance Program Act;
            
60

    
    (b)  a representative from the Insurance Commission selected by the Commissioner of
            
61

    
Insurance;
            
62

    
    (c)  a representative from the Department of Health selected by the executive director of
            
63

    
the Department of Health;
            
64

    
    (d)  a representative from the Comprehensive Health Insurance Pool, created in Title
            
65

    
31A, Chapter 29, Comprehensive Health Insurance Pool Act, selected by the board of directors
            
66

    
of the pool;
            
67

    
    (e)  a representative from the Department of Human Services selected by the executive
            
68

    
director of the Department of Human Services;
            
69

    
    (f)  a representative of higher education appointed by the State Board of Regents;
            
70

    
    (g)  a representative of public education appointed by the State School Board;
            
71

    
    (h)  a representative appointed by the Utah School Board's Association;
            
72

    
    (i)  a representative appointed by the State Office of Education;
            
73

    
    (j)  two representatives appointed by the Utah Association of School Business Officials
            
74

    
as follows:
            
75

    
    (i)  one representative from a local rural school district; and
            
76

    
    (ii)  one representative from an urban local school district;
            
77

    
    (k)  a representative from the Department of Corrections appointed by the executive
            
78

    
director of the department; and
            
79

    
    (l)  a representative of a political subdivision in the state appointed by the Utah
            
80

    
Association of Counties.
            
81

    
    (4) (a)  The department:
            
82

    
    (i)  shall establish an aggregate prescription drug purchasing program, in accordance
            
83

    
with this section, through which terms are negotiated related to the purchase of prescription
            
84

    
drugs by a state entity that provides coverage for prescription drugs or arranges for the payment
            
85

    
of the costs of prescription drugs; and
            
86

    
    (ii)  shall not implement or maintain the aggregate prescription drug purchasing
            
87

    
program established under Subsection (4)(a)(i), until:
            
88

    
    (A)  the audit report by the Legislative Auditor General's Office required by Subsection
            
89

    
(6); and

            
90


    
    (B)  after July 1, 2007.
            
91

    
    (b) (i)  A state entity as defined in Subsection (1) shall participate in the aggregate drug
            
92

    
purchasing program established by this section.
            
93

    
    (ii)  Any state, district, county, city, municipality, public agency, or governmental entity
            
94

    
other than a state entity defined in Subsection (1) may elect to participate in the aggregate
            
95

    
prescription drug purchasing program established by this section.
            
96

    
    (iii)  The state Medicaid program may participate in the aggregate prescription drug
            
97

    
purchasing program to the extent:
            
98

    
    (A)  permitted by federal law; and
            
99

    
    (B)  participation in the plan would reduce the Medicaid program's costs for
            
100

    
prescription drugs.
            
101

    
    (5)  The department, in consultation with the committee, may:
            
102

    
    (a)  investigate and implement options and strategies to achieve the greatest savings on
            
103

    
prescriptions drugs with prescription drug manufacturers and wholesalers;
            
104

    
    (b)  appoint and contract with a pharmaceutical benefits manager or any other entity to
            
105

    
do any of the following:
            
106

    
    (i)  negotiate price discounts, rebates, or other options that achieve the greatest savings
            
107

    
on prescription drugs with prescription drug manufacturers and wholesalers;
            
108

    
    (ii)  purchase prescription drugs for participating state, district, county, or municipal
            
109

    
governmental employees; or
            
110

    
    (iii)  act as a consultant to the department; or
            
111

    
    (c)  explore additional strategies for managing the increasing costs of prescription
            
112

    
drugs, including:
            
113

    
    (i)  coordinating programs offered by pharmaceutical manufacturers that provide
            
114

    
prescription drugs for free or at reduced prices;
            
115

    
    (ii)  study the feasibility and appropriateness of including in the aggregate purchasing
            
116

    
programs entities in the private sector, including employers, providers, and individual
            
117

    
consumers;
            
118

    
    (iii)  implementing other strategies, as permitted under state and federal law, aimed at
            
119

    
managing escalating prescription drug prices; and
            
120

    
    (iv)  enter into agreements with other states to jointly purchase prescription drugs in the

            
121


    
aggregate to reduce the prescription drug costs for the state.
            
122

    
    (6) (a)  On or before October 1, 2006, the department shall submit a report to the
            
123

    
Legislative Auditor General's Office on activities that have been or will be undertaken pursuant
            
124

    
to this section.  The report shall include all of the following:
            
125

    
    (i)  the number and description of contracts that are contemplated with manufacturers
            
126

    
and suppliers of drugs, including any rebates, discounts, or refunds to be obtained under the
            
127

    
contracts;
            
128

    
    (ii)  the number and a description of state entities participating in the coordinated
            
129

    
purchasing program;
            
130

    
    (iii)  other options and strategies that have been or will be implemented under the
            
131

    
program; and
            
132

    
    (iv)  estimated costs and savings attributable to activities that have been or will be
            
133

    
undertaken pursuant to this section.
            
134

    
    (b)  The Legislative Auditor General will conduct an audit of the program proposed
            
135

    
under this section and shall submit the results of the audit to the Legislature before January 1,
            
136

    
2007.
            
137

    
    (7)  Information that includes prescription drug prices and discounts or other proprietary
            
138

    
information, trade secrets, or commercial information provided to the committee or to the
            
139

    
department under the provisions of this section may be classified as protected records in
            
140

    
accordance with Section 

63-2-304

 of the Government Records Access and Management Act.




 Legislative Review Note
    as of  12-19-05  3:53 PM

Based on a limited legal review, this legislation has not been determined to have a high
probability of being held unconstitutional.

 Office of Legislative Research and General Counsel
[Bill Documents][Bills Directory]









Who represents me?





Remember my Legislators





State Senate
		350 North State, Suite 320
		PO Box 145115
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1035
		Fax: (801) 326-1475



House of Representatives
		350 North State, Suite 350
		PO Box 145030
		Salt Lake City, Utah 84114

		Telephone: (801) 538-1029
		Fax: (801) 326-1544










Home
Mobile Site
Site Map
Calendar
Code / Constitution
House
Senate

Terms of Use/Privacy Policy

ADA
Utah.gov







